Treatment Decision-Making for HR-MDS Patients image

Treatment Decision-Making for HR-MDS Patients

May 08, 2024
03:00PM - 04:00PM EDT
Online Event
Overview

Getting a High-Risk MDS diagnosis can be overwhelming. Dr. Taylor joins us to talk about HR-MDS, what kinds of treatment decisions patients have to make, and what can help inform those decisions.

Agenda
3:00 PM
Inrtoductions
Mary Arnett

Mary introduces the agenda for the event and featured speaker Dr. Justin Taylor.

3:05 PM
Presentation
Justin Taylor

Dr. Justin Taylor will present on decision making for HR-MDS patients.

3:40 PM
Questions & Answers
Audience

Type your questions in the chat and Dr. Taylor will answer them!

Speakers & Moderators
Healthtree contact Mary Arnett

Mary Arnett

Volunteer and Community Outreach Manager, HealthTree Foundation

Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Healthtree contact Justin Taylor

Justin Taylor

Leukemia Specialist

Justin Taylor, MD, is a physician-scientist devoted to improving outcomes for patients with hematologic malignancies. The Taylor lab studies the role of recurrent mutations in hematologic malignancies and how to target them with novel therapeutics using animal modeling, molecular biology, and single-cell genomic techniques. Dr. Taylor holds a faculty position in the Department of Medicine, Division of Hematology where he sees patients with hematologic malignancies. He is the principal investigator on grants sponsored by the National Cancer Institute (K08), American Society of Hematology, the Robert Wood Johnson Foundation and the Edward P. Evans Foundation for MDS. He has received Young Investigator Awards from ASCO Conquer Cancer Foundation, Hairy Cell Leukemia Foundation, and Evans MDS Foundation.